This protocol addresses individuals with Friedreich ataxia who present with lower urinary tract symptoms (LUTS), specifically urinary storage symptoms consistent with an overactive bladder pattern.
Before initiating pharmacological therapy, a structured pre-treatment assessment is recommended — including exclusion of a concomitant urinary tract infection and evaluation of post-micturition residual urine. A trial of antimuscarinic agents may then be considered for eligible individuals.
DOI: 10.1186/s13023-022-02568-3
View source ↗